A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Clinical trial NCT06850922 · COMPLETED
Trial details
- NCT number
- NCT06850922
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2026-05-19
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.